Correlation
The correlation between JNJ and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
JNJ vs. ABBV
Compare and contrast key facts about Johnson & Johnson (JNJ) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JNJ or ABBV.
Performance
JNJ vs. ABBV - Performance Comparison
Loading data...
Key characteristics
JNJ:
0.55
ABBV:
0.83
JNJ:
0.89
ABBV:
1.21
JNJ:
1.12
ABBV:
1.19
JNJ:
0.64
ABBV:
1.17
JNJ:
1.68
ABBV:
2.66
JNJ:
6.54%
ABBV:
9.07%
JNJ:
18.83%
ABBV:
28.28%
JNJ:
-52.60%
ABBV:
-45.09%
JNJ:
-8.05%
ABBV:
-13.31%
Fundamentals
JNJ:
$369.52B
ABBV:
$327.88B
JNJ:
$8.98
ABBV:
$2.34
JNJ:
17.10
ABBV:
79.32
JNJ:
1.04
ABBV:
0.40
JNJ:
4.14
ABBV:
5.72
JNJ:
4.73
ABBV:
230.90
JNJ:
$89.33B
ABBV:
$57.37B
JNJ:
$61.01B
ABBV:
$44.44B
JNJ:
$34.70B
ABBV:
$16.36B
Returns By Period
In the year-to-date period, JNJ achieves a 9.11% return, which is significantly higher than ABBV's 6.70% return. Over the past 10 years, JNJ has underperformed ABBV with an annualized return of 7.44%, while ABBV has yielded a comparatively higher 15.54% annualized return.
JNJ
9.11%
0.15%
1.79%
10.31%
-1.81%
3.76%
7.44%
ABBV
6.70%
-4.61%
3.65%
23.40%
12.26%
19.77%
15.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JNJ vs. ABBV — Risk-Adjusted Performance Rank
JNJ
ABBV
JNJ vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
JNJ vs. ABBV - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 3.23%, less than ABBV's 3.43% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 3.23% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
ABBV AbbVie Inc. | 3.43% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
JNJ vs. ABBV - Drawdown Comparison
The maximum JNJ drawdown since its inception was -52.60%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for JNJ and ABBV.
Loading data...
Volatility
JNJ vs. ABBV - Volatility Comparison
The current volatility for Johnson & Johnson (JNJ) is 6.09%, while AbbVie Inc. (ABBV) has a volatility of 9.85%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
JNJ vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JNJ vs. ABBV - Profitability Comparison
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.